到 2030 年金奈米顆粒市場預測:按類型、應用、最終用戶和地區分類的全球分析
市場調查報告書
商品編碼
1383466

到 2030 年金奈米顆粒市場預測:按類型、應用、最終用戶和地區分類的全球分析

Gold Nanoparticles Market Forecasts to 2030 - Global Analysis By Type, Application, End User and by Geography

出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3個工作天內

價格

根據Stratistics MRC的數據,2023年全球金奈米顆粒市場規模為38.1億美元,預計2030年將達到98.9億美元,預測期內年複合成長率為14.6%。

金奈米顆粒是一種用途廣泛、研究廣泛的奈米材料,典型尺寸範圍為 1 至 100 奈米。它們獨特的光學特性,包括與尺寸和形狀相關的明亮顏色,使其可用於成像、藥物傳輸和醫療診斷。這些奈米顆粒因其生物相容性而受到高度重視,可實現標靶治療和生物感測器。

根據美國測試與材料協會 (ASTM International 2006) 的說法,奈米顆粒是具有二維或更多維度且尺寸範圍為 1 至 100 nm 的顆粒。

日益成長的環境問題

隨著空氣和水污染等環境問題的日益嚴重,金奈米顆粒越來越受歡迎。金奈米顆粒用於許多環境應用,例如空氣污染監測和水淨化。此外,金奈米粒子催化污染物分解的能力及其在環境毒素檢測感測器中的應用與世界對環境保護和永續性的關注相一致。

生產成本高

原料成本、能源使用和合成技術的難度是影響金奈米顆粒製造成本的一些變數。由於特殊應用需要精確控制尺寸和形狀,因此製造成本很高。此外,由於在大批量生產中保持品質和粒度分佈一致性的技術挑戰,實現規模經濟可能很困難。對成本敏感的行業和應用的採用可能會受到此成本因素的限制。

醫療領域的發展

使用金奈米粒子在醫學領域有很多可能性。其特殊的性質可以實現藥物的靶向輸送,從而實現精確的藥物輸送,同時減少副作用。它也是疾病早期診斷和檢測的有用工具,特別是感染疾病和癌症的診斷。此外,隨著醫學研究的進步,金奈米粒子有可能透過提高治療效果和診斷準確性來徹底改變醫療保健。

與不同奈米材料的競爭

金奈米顆粒面臨的主要競爭威脅之一是開發具有可比或更好性能但成本更低的替代奈米材料。而且,量子點、奈米銀、碳基奈米材料等材料都有可能改變消費者的需求,所以企業不斷想出新的想法,宣傳奈米金的特殊好處,我必須繼續下去。

COVID-19 的影響:

金奈米顆粒市場受到了 COVID-19大流行的各種影響。一方面,由於疫苗輸送和診斷等醫療和診斷應用對金奈米顆粒的需求不斷增加,市場不斷成長。即使在疫情過後,金奈米粒子的市場預計仍將擴大,特別是在環境和醫療保健產業。然而,要警惕供應鏈的弱點和經濟的不可預測性。

預計藥物傳輸領域在預測期內將是最大的

藥物傳輸領域預計將佔據最大的市場佔有率。金奈米顆粒的特殊性質使其在藥物傳輸應用中非常受歡迎。透過設計這些奈米粒子,可以將治療藥物精確地遞送到特定的細胞和組織。透過對金奈米粒子表面進行功能化,可以提高其生物相容性並延長血液循環。此外,它們的尺寸和形狀可以調整,因此可以客製化以滿足您的特定治療需求。

生技公司領域預計在預測期內年複合成長率最高。

在金奈米粒子市場中,複合年複合成長率最高的領域是生技公司。金奈米粒子在藥物傳輸、成像、診斷和治療等生物技術應用中越來越普及。金奈米粒子由於其特殊的光學、熱和電特性而非常適合用於生物醫學應用。此外,具有特定配體和生物分子的金奈米顆粒的功能化可以進一步增強其在標靶藥物遞送和成像方面的潛力。

比最大的地區

北美,包括美國和加拿大,在金奈米粒子市場中佔據最大佔有率。該地區因其在材料科學、醫療保健和奈米技術方面強大的研發實力而擁有強大的市場影響力。此外,由於北美研究機構、製藥公司和生物技術公司的努力,對金奈米粒子的需求正在顯著成長。

複合年複合成長率最高的地區:

預計歐洲地區金奈米粒子市場的年複合成長率最高。此外,金奈米粒子具有廣泛的應用,包括成像、藥物傳輸和診斷,而醫療保健和生物技術研究的這些發展是其顯著成長的來源。憑藉對奈米技術研究的大力支持和對創新的奉獻,歐洲有望引領市場擴張。

免費客製化服務:

訂閱此報告的客戶可以存取以下免費自訂選項之一:

  • 公司簡介
    • 其他市場參與者的綜合分析(最多 3 家公司)
    • 主要企業SWOT分析(最多3家企業)
  • 區域分割
    • 根據客戶興趣對主要國家的市場估計、預測和年複合成長率(註:基於可行性檢查)
  • 競爭基準化分析
    • 根據產品系列、地理分佈和策略聯盟對主要企業基準化分析

目錄

第1章 執行摘要

第2章 前言

  • 概述
  • 利害關係人
  • 調查範圍
  • 調查方法
    • 資料探勘
    • 資料分析
    • 資料檢驗
    • 研究途徑
  • 調查來源
    • 主要調查來源
    • 二次調查來源
    • 先決條件

第3章 市場趨勢分析

  • 促進因素
  • 抑制因素
  • 機會
  • 威脅
  • 應用分析
  • 最終用戶分析
  • 新興市場
  • 新型冠狀病毒感染疾病(COVID-19)的影響

第4章 波特五力分析

  • 供應商的議價能力
  • 買方議價能力
  • 替代品的威脅
  • 新進入者的威脅
  • 競爭公司之間的敵對關係

第5章 全球金奈米顆粒市場:依類型

  • 基於金奈米顆粒的藥物傳輸系統
  • 聚乙二醇化金奈米顆粒
  • 金奈米殼
  • 金奈米粒子顯影劑
  • 其他類型

第6章 全球金奈米顆粒市場:依應用分類

  • 感應器
  • 光熱療法
  • 電子產品
  • 創傷治療
  • 化妝品
  • 奈米流體
  • 食品工業
  • 紡織品
  • 淨水
  • 藥物輸送
  • 其他用途

第7章 全球金奈米顆粒市場:依最終用戶分類

  • 製藥公司
  • 醫院和診所
  • 研究機構
  • 生技公司
  • 牙醫診所
  • 動物醫院
  • 其他最終用戶

第8章 全球金奈米顆粒市場:按地區

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 義大利
    • 法國
    • 西班牙
    • 其他歐洲國家
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 紐西蘭
    • 韓國
    • 其他亞太地區
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 南美洲其他地區
  • 中東和非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 卡達
    • 南非
    • 其他中東和非洲

第9章 進展

  • 合約、夥伴關係、協作和合資企業
  • 收購和合併
  • 新產品發布
  • 業務擴展
  • 其他關鍵策略

第10章 公司簡介

  • NanoComposix
  • Agilent Technologies Inc.
  • Expedeon Ltd.
  • BBI Solutions
  • NanoHybrids Inc
  • Meliorum Technologies Inc
  • Cline Scientific
  • Nanopartz Inc
  • Goldsol Inc
  • Abcam plc
  • Merck Group
  • Cytodiagnostics Inc
  • Nanosphere Inc
  • Metalor Technologies International
  • Solaris Nanosciences Corporation
  • Sigma-Aldrich
  • Tanaka Holdings Co., Ltd
  • Sona Nanotech Inc
  • Strem Chemicals Inc.
Product Code: SMRC24314

According to Stratistics MRC, the Global Gold Nanoparticles Market is accounted for $3.81 billion in 2023 and is expected to reach $9.89 billion by 2030 growing at a CAGR of 14.6% during the forecast period. Gold nanoparticles are a versatile and widely studied nanomaterial, with typical sizes ranging from 1 to 100 nanometers. Their unique optical characteristics, such as their size- and shape-dependent vivid colors, make them useful for imaging, medication delivery, and medical diagnostics. Due to their biocompatibility, which enables targeted treatments and biosensors, these nanoparticles are highly valued.

According to American Society for Testing and Materials (ASTM international 2006), nanoparticles are those particles which have two or more than two dimensions and are in the size range of 1 - 100 nm.

Market Dynamics:

Driver:

Growing Concerns about the Environment

Gold nanoparticles are becoming more popular as environmental concerns-such as air and water pollution-get bigger. They are used in a number of environmental applications, including air pollution monitoring and water purification. Moreover, the ability of gold nanoparticles to catalyze the breakdown of pollutants and their application in environmental toxin detection sensors are in line with the global focus on environmental protection and sustainability.

Restraint:

High production expenses

The cost of raw materials, energy usage, and the difficulty of synthesis techniques are some of the variables that affect the cost of producing gold nanoparticles. Higher production costs result from the need for precise control over size and shape in specialized applications. Furthermore, it can be difficult to achieve economies of scale because it can be technically difficult to maintain consistency in quality and size distribution at higher volumes. Their adoption in cost-sensitive industries and applications may be restricted by this cost factor.

Opportunity:

Developments in medicine

There are a lot of opportunities in the field of medicine with gold nanoparticles. Their special qualities can be used to deliver drugs with precision and fewer side effects by allowing for targeted delivery. They are also useful instruments for early illness diagnosis and detection, particularly in the diagnosis of infectious diseases and cancer. Additionally, gold nanoparticles have the potential to completely transform healthcare as medical research progresses by increasing treatment efficacy and diagnostic precision.

Threat:

Rivalry with different nanomaterials

One major competitive threat to gold nanoparticles is the development of substitute nanomaterials with comparable or better properties but at a lower price. Moreover, materials like quantum dots, silver nanoparticles, and carbon-based nanomaterials can change consumer demand, which forces businesses to keep coming up with new ideas and showcasing the special benefits of gold nanoparticles.

COVID-19 Impact:

The market for gold nanoparticles has been affected by the COVID-19 pandemic in many ways. On the one hand, the market was growing due to the increase in demand for gold nanoparticles in medical and diagnostic applications, such as vaccine delivery and diagnostics. The market for gold nanoparticles is anticipated to expand after the pandemic passes, especially in the environmental and healthcare industries. However, caution should be exercised regarding supply chain weaknesses and economic unpredictability.

The Drug Delivery segment is expected to be the largest during the forecast period

The drug delivery segment is anticipated to hold the largest share in the market. The special qualities of gold nanoparticles have made them very popular in drug delivery applications. Therapeutic agents can be precisely delivered to particular cells or tissues by engineering these nanoparticles. It is possible to functionalize the surface of gold nanoparticles to improve their biocompatibility and lengthen their bloodstream circulation. Furthermore, they can be customized to meet specific therapeutic needs thanks to their adjustable size and shape.

The Biotechnology Companies segment is expected to have the highest CAGR during the forecast period

In the market for gold nanoparticles, the segment with the highest CAGR is biotechnology companies. Gold nanoparticles are becoming more and more popular in biotechnology applications such as drug delivery, imaging, diagnostics, and therapeutics. Gold nanoparticles are ideal for use in biomedical applications because of their special optical, thermal, and electrical characteristics. Moreover, the potential of gold nanoparticles in targeted drug delivery and imaging can be further enhanced by functionalizing them with particular ligands and biomolecules.

Region with largest share:

North America, which includes both the United States and Canada, holds the largest share of the market for gold nanoparticles. Due to the region's intense research and development efforts in material science, healthcare, and nanotechnology, it has a strong market presence. Moreover, the demand for gold nanoparticles has grown significantly, in large part due to the efforts of research institutions, pharmaceutical companies, and biotechnology firms in North America.

Region with highest CAGR:

In the market for gold nanoparticles, the European region is anticipated to have the highest CAGR. Additionally, gold nanoparticles find wide-ranging applications in imaging, drug delivery, and diagnostics; these developments in healthcare and biotechnology research are the source of this noteworthy growth. With its strong support for nanotechnology research and its dedication to innovation, Europe is well-positioned to lead the way in propelling market expansion.

Key players in the market

Some of the key players in Gold Nanoparticles market include: NanoComposix , Agilent Technologies Inc., Expedeon Ltd., BBI Solutions, NanoHybrids Inc, Meliorum Technologies Inc, Cline Scientific, Nanopartz Inc, Goldsol Inc, Abcam plc, Merck Group, Cytodiagnostics Inc, Nanosphere Inc, Metalor Technologies International, Solaris Nanosciences Corporation , Sigma-Aldrich , Tanaka Holdings Co., Ltd, Sona Nanotech Inc and Strem Chemicals Inc.

Key Developments:

In October2023, TANAKA, a core company of the TANAKA Precious Metals Group, has developed a high-entropy alloy powder composed entirely of precious metals with a fine particle size of 10um or less, high crystallinity and excellent composition uniformity. This is the world's first high-entropy alloy powder composed entirely of five precious metals: platinum, palladium, iridium, ruthenium, and rhodium. TANAKA has established a mass production process and will provide samples in October.

In March 2023, Agilent Technologies Inc. announced a multi-year distribution agreement with Proscia, a leader in digital pathology to offer a comprehensive digital diagnostic pathology system. Combining Agilent's trusted pathology staining solutions with Proscia's Concentriq Dx enterprise pathology platform will empower pathology labs to transform diagnostic efficiency and quality to improve patient health outcomes.

In May 2020, NanoComposix has established a partnership with Amplicon Biotech to expand access for customers across India to the suite of products and services offered by nanoComposix, a manufacturer of a variety of nanoparticle products for use in lateral flow assays, drug delivery, anti-microbials, optical displays, among other applications.

Types Covered:

  • Gold Nanoparticle-Based Drug Delivery Systems
  • Pegylated Gold Nanoparticles
  • Gold Nanoshells
  • Gold Nanoparticle-Based Contrast Agents
  • Other Types

Applications Covered:

  • Sensors
  • Photothermal Therapy
  • Electronics
  • Wound Healing
  • Cosmetics
  • Nanofluids
  • Food Industry
  • Textiles
  • Water Purification
  • Drug Delivery
  • Other Applications

End Users Covered:

  • Pharmaceutical Companies
  • Hospitals and Clinics
  • Research Institutions
  • Biotechnology Companies
  • Dental Clinics
  • Veterinary Clinics
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Application Analysis
  • 3.7 End User Analysis
  • 3.8 Emerging Markets
  • 3.9 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Gold Nanoparticles Market, By Type

  • 5.1 Introduction
  • 5.2 Gold Nanoparticle-Based Drug Delivery Systems
  • 5.3 Pegylated Gold Nanoparticles
  • 5.4 Gold Nanoshells
  • 5.5 Gold Nanoparticle-Based Contrast Agents
  • 5.6 Other Types

6 Global Gold Nanoparticles Market, By Application

  • 6.1 Introduction
  • 6.2 Sensors
  • 6.3 Photothermal Therapy
  • 6.4 Electronics
  • 6.5 Wound Healing
  • 6.6 Cosmetics
  • 6.7 Nanofluids
  • 6.8 Food Industry
  • 6.9 Textiles
  • 6.10 Water Purification
  • 6.11 Drug Delivery
  • 6.12 Other Applications

7 Global Gold Nanoparticles Market, By End User

  • 7.1 Introduction
  • 7.2 Pharmaceutical Companies
  • 7.3 Hospitals and Clinics
  • 7.4 Research Institutions
  • 7.5 Biotechnology Companies
  • 7.6 Dental Clinics
  • 7.7 Veterinary Clinics
  • 7.8 Other End Users

8 Global Gold Nanoparticles Market, By Geography

  • 8.1 Introduction
  • 8.2 North America
    • 8.2.1 US
    • 8.2.2 Canada
    • 8.2.3 Mexico
  • 8.3 Europe
    • 8.3.1 Germany
    • 8.3.2 UK
    • 8.3.3 Italy
    • 8.3.4 France
    • 8.3.5 Spain
    • 8.3.6 Rest of Europe
  • 8.4 Asia Pacific
    • 8.4.1 Japan
    • 8.4.2 China
    • 8.4.3 India
    • 8.4.4 Australia
    • 8.4.5 New Zealand
    • 8.4.6 South Korea
    • 8.4.7 Rest of Asia Pacific
  • 8.5 South America
    • 8.5.1 Argentina
    • 8.5.2 Brazil
    • 8.5.3 Chile
    • 8.5.4 Rest of South America
  • 8.6 Middle East & Africa
    • 8.6.1 Saudi Arabia
    • 8.6.2 UAE
    • 8.6.3 Qatar
    • 8.6.4 South Africa
    • 8.6.5 Rest of Middle East & Africa

9 Key Developments

  • 9.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 9.2 Acquisitions & Mergers
  • 9.3 New Product Launch
  • 9.4 Expansions
  • 9.5 Other Key Strategies

10 Company Profiling

  • 10.1 NanoComposix
  • 10.2 Agilent Technologies Inc.
  • 10.3 Expedeon Ltd.
  • 10.4 BBI Solutions
  • 10.5 NanoHybrids Inc
  • 10.6 Meliorum Technologies Inc
  • 10.7 Cline Scientific
  • 10.8 Nanopartz Inc
  • 10.9 Goldsol Inc
  • 10.10 Abcam plc
  • 10.11 Merck Group
  • 10.12 Cytodiagnostics Inc
  • 10.13 Nanosphere Inc
  • 10.14 Metalor Technologies International
  • 10.15 Solaris Nanosciences Corporation
  • 10.16 Sigma-Aldrich
  • 10.17 Tanaka Holdings Co., Ltd
  • 10.18 Sona Nanotech Inc
  • 10.19 Strem Chemicals Inc.

List of Tables

  • Table 1 Global Gold Nanoparticles Market Outlook, By Region (2021-2030) ($MN)
  • Table 2 Global Gold Nanoparticles Market Outlook, By Type (2021-2030) ($MN)
  • Table 3 Global Gold Nanoparticles Market Outlook, By Gold Nanoparticle-Based Drug Delivery Systems (2021-2030) ($MN)
  • Table 4 Global Gold Nanoparticles Market Outlook, By Pegylated Gold Nanoparticles (2021-2030) ($MN)
  • Table 5 Global Gold Nanoparticles Market Outlook, By Gold Nanoshells (2021-2030) ($MN)
  • Table 6 Global Gold Nanoparticles Market Outlook, By Gold Nanoparticle-Based Contrast Agents (2021-2030) ($MN)
  • Table 7 Global Gold Nanoparticles Market Outlook, By Other Types (2021-2030) ($MN)
  • Table 8 Global Gold Nanoparticles Market Outlook, By Application (2021-2030) ($MN)
  • Table 9 Global Gold Nanoparticles Market Outlook, By Sensors (2021-2030) ($MN)
  • Table 10 Global Gold Nanoparticles Market Outlook, By Photothermal Therapy (2021-2030) ($MN)
  • Table 11 Global Gold Nanoparticles Market Outlook, By Electronics (2021-2030) ($MN)
  • Table 12 Global Gold Nanoparticles Market Outlook, By Wound Healing (2021-2030) ($MN)
  • Table 13 Global Gold Nanoparticles Market Outlook, By Cosmetics (2021-2030) ($MN)
  • Table 14 Global Gold Nanoparticles Market Outlook, By Nanofluids (2021-2030) ($MN)
  • Table 15 Global Gold Nanoparticles Market Outlook, By Food Industry (2021-2030) ($MN)
  • Table 16 Global Gold Nanoparticles Market Outlook, By Textiles (2021-2030) ($MN)
  • Table 17 Global Gold Nanoparticles Market Outlook, By Water Purification (2021-2030) ($MN)
  • Table 18 Global Gold Nanoparticles Market Outlook, By Drug Delivery (2021-2030) ($MN)
  • Table 19 Global Gold Nanoparticles Market Outlook, By Other Applications (2021-2030) ($MN)
  • Table 20 Global Gold Nanoparticles Market Outlook, By End User (2021-2030) ($MN)
  • Table 21 Global Gold Nanoparticles Market Outlook, By Pharmaceutical Companies (2021-2030) ($MN)
  • Table 22 Global Gold Nanoparticles Market Outlook, By Hospitals and Clinics (2021-2030) ($MN)
  • Table 23 Global Gold Nanoparticles Market Outlook, By Research Institutions (2021-2030) ($MN)
  • Table 24 Global Gold Nanoparticles Market Outlook, By Biotechnology Companies (2021-2030) ($MN)
  • Table 25 Global Gold Nanoparticles Market Outlook, By Dental Clinics (2021-2030) ($MN)
  • Table 26 Global Gold Nanoparticles Market Outlook, By Veterinary Clinics (2021-2030) ($MN)
  • Table 27 Global Gold Nanoparticles Market Outlook, By Other End Users (2021-2030) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.